News about "Lonza"

Iconovo and Lonza to Develop Formulation of Intranasal Biologic

This project, with a reformulated substance for obesity, is the first in Iconovo’s strategic initiative to reformulate known pharmaceuticals and replace injections and oral treatments with inhalation.

Lonza | 14/01/2025 | By Aishwarya

Lonza Completes its First GMP Batch of Next-Gen Mammalian Manufacturing Facility in US

The first GMP batch release marks a significant milestone, allowing the facility to help meet the increasing market demand for small- to mid-scale volumes of mammalian-derived biologics and support the implementation of high-titer and high-throughput platform processes.

Lonza | 25/11/2024 | By Aishwarya

Acumen Pharma Extends Partnership with Lonza to Support Manufacturing of Sabirnetug

Sabirnetug is the first humanized monoclonal antibody to clinically demonstrate selective target engagement of AβOs in AD patients.

Lonza | 30/09/2024 | By Aishwarya

Lonza Inaugurates Innovaform Accelerator CoE in France

The new Innovaform Accelerator will serve as a Center of Excellence (CoE) for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.

Lonza | 20/09/2024 | By Aishwarya |  104

Champalimaud Foundation to Leverage Lonza Platform to Advance Cell Therapy

Champalimaud Foundation, a biomedical clinical research organization carrying out research and cutting-edge clinical development and discoveries that benefit people, and Lonza have announced the installation of Lonza’s MODA-ES Platform at the Champalimaud Clinical Centre in Lisbon, Portugal.

Lonza | 13/08/2024 | By Aishwarya |  174

TriLink Signs Non-Exclusive License and Supply Agreement with Lonza

TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.

Lonza | 02/05/2024 | By Aishwarya |  244

Acumen Pharmaceuticals Join Hands with Lonza to Bolster Sabirnetug Production

Acumen Pharmaceuticals has signed a partnership agreement with Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets.

Lonza | 05/04/2024 | By Aishwarya |  230

Lonza and Vertex to Establish Manufacturing Facility for Cell Therapy in Portsmouth

The facility marks a milestone in the strategic collaboration between the two firms.

Lonza | 01/09/2023 | By Manvi |  492

Lonza completes expansion at Oregon site

The project included the remodelling of laboratory space used to develop early-stage compounds

Lonza | 18/01/2023 | By Sudeep Soparkar |  353

Lonza begins commercial operations of API manufacturing centre in Nansha, China

The expansion includes six 1,000L reactors, four 1,500L reactors, and isolation equipment providing mid-scale capacity to bridge between early-phase and late-phase production

Lonza | 06/12/2022 | By Sudeep Soparkar |  494